Research Progress of Miao Medicine in the Treatment of Glucolipid Metabolic Disease
- VernacularTitle:苗药治疗糖脂代谢性疾病的研究进展
- Author:
Yuqing LIU
1
,
2
;
Xiuteng ZHOU
;
Duosheng LUO
Author Information
- Keywords: Miao medicine; Glucolipid metabolic disease; Hyperlipidemia; Diabetes mellitus; Non-alcoholic fatty liver disease; Atherosclerosis
- From: World Science and Technology-Modernization of Traditional Chinese Medicine 2024;26(3):787-796
- CountryChina
- Language:Chinese
- Abstract: Glucolipid Metabolic Disease(GLMD)is a group of diseases closely related to disorders of glucose and lipid metabolism,mainly including hyperlipidemia,non-alcoholic fatty liver,diabetes,atherosclerosis,etc.The incidence is increasing year by year and poses a serious threat to national health.Miao medicine is an important part of traditional medicine in China,with rich resources and great characteristics,and has advantages in the treatment of glucolipid metabolic disease,but there is no systematic literature combing about Miao medicine for this kind of disease.In this paper,we reviewed the literature related to the treatment of glucolipid metabolic diseases by Miao medicine in recent years through data search,based on the commonly used Miao medicines recorded in the Chinese Materia Medica,and summarized the research progress of its pharmacological effects,mechanism of action,and clinical application,in order to provide reference basis and research ideas for the in-depth research development and utilization of Miao medicine.
